H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global H1N1 vaccines market size reached US$ 3.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.11% during 2023-2028.
The H1N1 virus is an infectious disease characterized by a persistent cough, high fever, red-watery eyes, body aches and headache. The illness is known to have a detrimental effect on the existing chronic ailments, such as Pneumonia, Chronic Obstructive Pulmonary Disease (COPD) and Bronchitis, and can be fatal in severe cases. H1N1 vaccines are a preventive measure administered through intradermal and intranasal procedures to provide active immunization against the virus.
Increasing incidences of epidemic H1N1 infection and declining immunity of the general population are among the key factors driving the market growth. With increasing age, the risk of developing respiratory tract diseases and immunodeficiency disorders also escalates, thereby increasing the risk of acquiring the H1N1 flu infection. However, extensive research and development in the field of immunology and vaccine technologies coupled with extensive support from global health organizations are expected to promote the distribution of quality vaccines. Moreover, a number of developed countries such as Australia, the United Kingdom, and the United States have also included H1N1 vaccinations under their National Immunization Program (NIP) that has increased the demand for these vaccines. Additionally, technological advancements coupled with a rising awareness amongst patients about preventive methods has also led to a heightened demand for H1N1 vaccines.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global H1N1 vaccines market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on vaccine type, key brands and market type.
Breakup by Vaccine Type:
Intramuscular
Intranasal
Intradermal
Breakup by Market Type:
Public
Private
Analysis of Key Brands:
Agripal
Fiuarix
Influgen
Influvac
Nasovac
Vaxigrip
Others
Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Competitive Landscape:
The report has also examined the competitive landscape of the market and provides the profiles of the key players operating in the industry.
IMARC Group’s latest report provides a deep insight into the global H1N1 vaccines market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global H1N1 vaccines industry in any manner.
Key Questions Answered in This Report:
How has the global H1N1 vaccines market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global H1N1 vaccines industry?
What are the popular vaccines type?
What are the major market types?
What are the various stages in the value chain of the global H1N1 vaccines industry?
What are the key driving factors and challenges in the global H1N1 vaccines market?
What is the structure of the global H1N1 vaccines industry and who are the key players?
What is the degree of competition in the industry?
What are the profit margins in the industry?
The H1N1 virus is an infectious disease characterized by a persistent cough, high fever, red-watery eyes, body aches and headache. The illness is known to have a detrimental effect on the existing chronic ailments, such as Pneumonia, Chronic Obstructive Pulmonary Disease (COPD) and Bronchitis, and can be fatal in severe cases. H1N1 vaccines are a preventive measure administered through intradermal and intranasal procedures to provide active immunization against the virus.
Increasing incidences of epidemic H1N1 infection and declining immunity of the general population are among the key factors driving the market growth. With increasing age, the risk of developing respiratory tract diseases and immunodeficiency disorders also escalates, thereby increasing the risk of acquiring the H1N1 flu infection. However, extensive research and development in the field of immunology and vaccine technologies coupled with extensive support from global health organizations are expected to promote the distribution of quality vaccines. Moreover, a number of developed countries such as Australia, the United Kingdom, and the United States have also included H1N1 vaccinations under their National Immunization Program (NIP) that has increased the demand for these vaccines. Additionally, technological advancements coupled with a rising awareness amongst patients about preventive methods has also led to a heightened demand for H1N1 vaccines.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global H1N1 vaccines market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on vaccine type, key brands and market type.
Breakup by Vaccine Type:
Intramuscular
Intranasal
Intradermal
Breakup by Market Type:
Public
Private
Analysis of Key Brands:
Agripal
Fiuarix
Influgen
Influvac
Nasovac
Vaxigrip
Others
Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Competitive Landscape:
The report has also examined the competitive landscape of the market and provides the profiles of the key players operating in the industry.
IMARC Group’s latest report provides a deep insight into the global H1N1 vaccines market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global H1N1 vaccines industry in any manner.
Key Questions Answered in This Report:
How has the global H1N1 vaccines market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global H1N1 vaccines industry?
What are the popular vaccines type?
What are the major market types?
What are the various stages in the value chain of the global H1N1 vaccines industry?
What are the key driving factors and challenges in the global H1N1 vaccines market?
What is the structure of the global H1N1 vaccines industry and who are the key players?
What is the degree of competition in the industry?
What are the profit margins in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL H1N1 VACCINES MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Breakup by Vaccines Type
5.5 Breakup by Market Type
5.6 Analysis of Key Brands
5.7 Breakup by Region
5.8 Market Forecast
6 MARKET BREAKUP BY VACCINES TYPE
6.1 Intramuscular
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intranasal
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Intradermal
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY TYPE
7.1 Public
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Private
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY REGION
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Latin America
8.5.1 Market Trends
8.5.2 Market Forecast
9 ANALYSIS OF KEY BRAND
9.1 Agripal
9.2 Fiuarix
9.3 Influgen
9.4 Influvac
9.5 Nasovac
9.6 Vaxigrip
9.7 Others
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis
14 INDUSTRY DEVELOPMENTS
14.1 Pipeline and New Product Launches
14.2 Mergers & Acquisitions and Partnerships
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL H1N1 VACCINES MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Breakup by Vaccines Type
5.5 Breakup by Market Type
5.6 Analysis of Key Brands
5.7 Breakup by Region
5.8 Market Forecast
6 MARKET BREAKUP BY VACCINES TYPE
6.1 Intramuscular
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intranasal
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Intradermal
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY TYPE
7.1 Public
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Private
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY REGION
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Latin America
8.5.1 Market Trends
8.5.2 Market Forecast
9 ANALYSIS OF KEY BRAND
9.1 Agripal
9.2 Fiuarix
9.3 Influgen
9.4 Influvac
9.5 Nasovac
9.6 Vaxigrip
9.7 Others
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis
14 INDUSTRY DEVELOPMENTS
14.1 Pipeline and New Product Launches
14.2 Mergers & Acquisitions and Partnerships
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
LIST OF TABLES
Table 1: Global: H1N1 Vaccines Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: H1N1 Vaccines Market Forecast: Breakup by Vaccines Type (in Million US$), 2023-2028
Table 3: Global: H1N1 Vaccines Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 4: Global: H1N1 Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: H1N1 Vaccines Market Structure
Table 6: Global: H1N1 Vaccines Market: Key Players
Table 1: Global: H1N1 Vaccines Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: H1N1 Vaccines Market Forecast: Breakup by Vaccines Type (in Million US$), 2023-2028
Table 3: Global: H1N1 Vaccines Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 4: Global: H1N1 Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: H1N1 Vaccines Market Structure
Table 6: Global: H1N1 Vaccines Market: Key Players
LIST OF FIGURES
Figure 1: Global: H1N1 Vaccines Market: Major Drivers and Challenges
Figure 2: Global: H1N1 Vaccines Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: H1N1 Vaccines Market: Breakup by Vaccines Type (in %), 2022
Figure 4: Global: H1N1 Vaccines Market: Breakup by Type (in %), 2022
Figure 5: Global: H1N1 Vaccines Market: Breakup by Region (in %), 2022
Figure 6: Global: H1N1 Vaccines Industry: SWOT Analysis
Figure 7: Global: H1N1 Vaccines Industry: Value Chain Analysis
Figure 8: Global: H1N1 Vaccines Industry: Porter’s Five Forces Analysis
Figure 9: Global: H1N1 Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 10: Global: H1N1 Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: H1N1 Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: H1N1 Vaccines (Intranasal) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: H1N1 Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: H1N1 Vaccines (Intradermal) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: H1N1 Vaccines (Intradermal) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: H1N1 Vaccines (Public) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: H1N1 Vaccines (Public) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: H1N1 Vaccines (Private) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: H1N1 Vaccines (Private) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: North America: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: North America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Europe: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Europe: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Asia Pacific: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Asia Pacific: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Middle East and Africa: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Middle East and Africa: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Latin America: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Latin America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 1: Global: H1N1 Vaccines Market: Major Drivers and Challenges
Figure 2: Global: H1N1 Vaccines Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: H1N1 Vaccines Market: Breakup by Vaccines Type (in %), 2022
Figure 4: Global: H1N1 Vaccines Market: Breakup by Type (in %), 2022
Figure 5: Global: H1N1 Vaccines Market: Breakup by Region (in %), 2022
Figure 6: Global: H1N1 Vaccines Industry: SWOT Analysis
Figure 7: Global: H1N1 Vaccines Industry: Value Chain Analysis
Figure 8: Global: H1N1 Vaccines Industry: Porter’s Five Forces Analysis
Figure 9: Global: H1N1 Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 10: Global: H1N1 Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: H1N1 Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: H1N1 Vaccines (Intranasal) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: H1N1 Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: H1N1 Vaccines (Intradermal) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: H1N1 Vaccines (Intradermal) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: H1N1 Vaccines (Public) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: H1N1 Vaccines (Public) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: H1N1 Vaccines (Private) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: H1N1 Vaccines (Private) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: North America: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: North America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Europe: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Europe: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Asia Pacific: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Asia Pacific: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Middle East and Africa: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Middle East and Africa: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Latin America: H1N1 Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Latin America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
